Itacitinib

3 trials Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

7 Countries

Phase II

Phase II: 3

Oversight events:

1 temporary halt 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Chronic graft versus host disease 1 Myelofibrosis 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Incyte Corp. 1

All trials

3 total

SCLERITA - Safety and efficacy of itacitinib in adults with systemic sclerosis: a phase II, randomized, controlled trial Ended

2024-513648-27-00 Phase II 1 country Assistance Publique Hopitaux De Paris
INCB 39110-801 A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Stu… Ended

2022-501661-47-00 Phase II 6 countries Incyte Corp.
Treatment of non severe Hemophagocytosis Lymphohistiocytosis with ITACITINIB a Phase II prospective trial Ended

2024-513173-44-00 Phase II 1 country Assistance Publique Hopitaux De Paris

Showing 1–3 of 3 trials

← All drugs A–Z